Navigation Links
Nanopore opens new cellular doorway for drug transport
Date:10/23/2013

A living cell is built with barriers to keep things out and researchers are constantly trying to find ways to smuggle molecules in.‬ ‪Professor Giovanni Maglia (Biochemistry, Molecular and Structural Biology, KU Leuven) and his team have engineered a biological nanopore that acts as a selective revolving door through a cell's lipid membrane. The nanopore could potentially be used in gene therapy and targeted drug delivery.‬‬‬‬‬‬‬

All living cells are enclosed by a lipid membrane that separates the interior of the cell from the outside environment. The influx of molecules through the cell membrane is tightly regulated by membrane proteins that act as specific doorways for the trafficking of ions and nutrients. Membrane proteins can also be used by cells as weapons. Such proteins attack a cell by making holes nanopores in 'enemy' cell membranes. Ions and molecules leak from the holes, eventually causing cell death.‬‬

‪Researchers are now trying to use nanopores to smuggle DNA or proteins across membranes. Once inside a cell, the DNA molecule could re-programme the cell for a particular action. Professor Maglia explains: "‪We are now able to engineer biological nanopores, but the difficult part is to precisely control the passage of molecules through the nanopores' doorways. We do not want the nanopore to let everything in. Rather, we want to limit entry to specific genetic information in specific cells." ‬‬‬‬‬‬‬‬‬‬‬‬‬‬

‪Professor Maglia and his team succeeded in engineering a nanopore that works like a revolving door for DNA molecules. "We have introduced a selective DNA revolving door atop of the nanopore. Specific DNA keys in solution hybridise to the DNA door and are transported across the nanopore. A second DNA key on the other side of the nanopore then releases th
'/>"/>

Contact: Giovanni Maglia
giovanni.maglia@chem.kuleuven.be
32-163-27696
KU Leuven
Source:Eurekalert  

Page: 1 2

Related biology news :

1. DNA prefers to dive head first into nanopores
2. Temp-controlled nanopores may allow detailed blood analysis
3. New NIH awards focus on nanopore technology for DNA sequencing
4. 3-D RNA modeling opens scientific doors
5. Press accreditation opens for World Series of Science
6. Understanding why some people have propensity to disease
7. Major osteoporosis meeting opens in São Paulo
8. Next-generation sequencing technology opens doors to discoveries
9. Media registration opens for Neuroscience 2012, worlds largest brain science meeting
10. Cell research opens new avenues in combating neurodegenerative diseases
11. OpenStax Colleges free textbooks will save students $1 million this fall
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nanopore opens new cellular doorway for drug transport
(Date:12/10/2014)... You,ve been here before: you desperately need to sign into ... key or the answer to your secret question. What,s your ... Today, Hoyos Labs , a digital infrastructure security ... an end to the frustration that comes with usernames, passwords ... a user,s smartphone to acquire his or her biometrics to ...
(Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans ... of Medicine. Funding for this $50 million capital project ... be publicly launched next summer. The ... 60 series R.J. Reynolds Tobacco Company complex, adjacent to ... immediately with plans to be ready to welcome medical ...
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... 2013Universit Laval researchers have developed a highly effective method for ... low-emissions fuel for vehicles. The team led by Professor Frdric-Georges ... issue of the Journal of the American Chemical Society ... convert methanol into carbon dioxide in a single step using ...
... of genetically modified mice that Western University scientists call ... run far but they aren,t smart, is furthering the ... Marco Prado and his team at Robarts Research Institute ... of this neurotransmitter becomes available in the brain. ...
... 2013 Based on its recent analysis of the ... with the 2013 European Frost & Sullivan Award for ... originally used for medical point-of-care testing to create an ... test requires only a single-step DNA collection procedure from ...
Cached Biology News:Too green to be true? Researchers develop highly effective method for converting CO2 into methanol 2'Forrest Gump' mice show too much of a good thing, can be bad 2Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 2Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 3Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 4
(Date:12/24/2014)... Md. , Dec. 24, 2014  United ... today that Medtronic, Inc. (NYSE: MDT ... the U.S. Food and Drug Administration (FDA) for ... implantable drug infusion system (including a newly developed ... (treprostinil) Injection delivered intravenously to patients with ...
(Date:12/24/2014)... GMO corn cases filed across the United ... the process of being consolidated in a Kansas federal ... Re: Syngenta AG MIR 162 Corn Litigation, MDL No. ... of Kansas. , Management of the Syngenta GMO corn ... District Judge John W. Lungstrum.* , As a Missouri ...
(Date:12/24/2014)... 2014 The report provides ... its definition, classification, application and industry overview. ... process, and product cost structure. Production is ... analysis also covers upstream raw materials, equipment, ... trend and proposals. In the end, the ...
(Date:12/24/2014)... , Dec. 23, 2014 Vermillion, ... focused on gynecologic disease, announced today that investors ... , Birchview Fund LLC and several Vermillion directors ... unregistered shares of Vermillion,s common stock and warrants ... in a private placement.  Under ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... DUBLIN, October 28 , ... EU to Treat,hyperphosphataemia >1.78mmol/L in Chronic Kidney Disease Patients ... (LSE: SHP, NASDAQ: SHPGY ), the global specialty,biopharmaceutical ... Mutual Recognition Procedure for an extension to the current,indication ...
... ... An incident of terrorism, accident, or improper disposal of radioactive ... catastrophe would impact the population with increased cancer and associated illnesses ... distribution network. In response to this threat, Technical Associates created the ...
... Oct. 27 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... authorization in the European Union for rilonacept, an ... Syndromes (CAPS) with severe symptoms, including Familial Cold ... adults and children aged 12 years and older. ...
Cached Biology Technology:Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease 2Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease 3Shire Secures European Wide Label Extension for FOSRENOL(R) in Chronic Kidney Disease 4Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law 2Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law 3Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law 4Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 2Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 3Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 4Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 5Regeneron's Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) 6